SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-08-014460
Filing Date
2008-06-05
Accepted
2008-06-05 17:10:15
Documents
1
Period of Report
2008-06-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4207
  Complete submission text file 0001140361-08-014460.txt   6114
Mailing Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Issuer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O AFFYMETRIX INC 3420 CENTRAL EXPRESSWAY SANTA CLARA CA 95051
Business Address 408-731-5000
FODOR STEPHEN P A (Reporting) CIK: 0001240360 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51531 | Film No.: 08883732